Breaking News, Financial News

Financial Report: AMRI 4Q

Contract revenue for the quarter, which includes Discovery Services, Development and Small Scale Manufacturing, and Large Scale Manufacturing, was $49.6 million (+22%) and $195.5 million for the year (+20%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI 4Q Revenues: $56.4 million (+19%) 4Q Earnings: $3.1 million (loss of $800,000 in 4Q07) FY Revenues: $229.3 million (+19%) FY Earnings: $20.6 million (+130%) Comments: Contract revenue for the quarter, which includes Discovery Services, Development and Small Scale Manufacturing, and Large Scale Manufacturing, was $49.6 million (+22%) and $195.5 million for the year (+20%). Discovery Services revenue was $13.1 million in the quarter (+13%) and $57.8 million for the year (+39%)....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters